Top Tweets for #IWorkAtAbbott
Lots to look forward to at #UKMedLab22 in London next week! Come to Abbott’s lunchtime scientific sessions; 1) Clinical Decision Support technology to transform in diagnostic pathways 2) novel biomarkers to help with assessment of mTBI @TheACBNews @AbbottNews #iworkatabbott
So proud to announce that I have started a new role with Abbott as their US Transfusion Medical Director! I am excited to engage with product users, collaborate, and build better solutions for the future in a patient centric organization.
#iworkatabbott #proudtobeabbott
A great resource for those preparing to take their exams #iworkatabbott
Fantastic sessions filled with great case based discussions and EGMs
Mijn werkgever is voor de 3e keer @TopEmployersNL geworden. Daarom een bosje bloemen gekregen! #IWorkAtAbbott #ProudToBeAbbott #Abbottemp
RT @AbbottNews We’re making a big impact for the tiniest babies suffering from a life-threatening opening in their heart.
@MassDevice shares how our Amplatzer Piccolo Occluder device was developed:
Safety info: #iworkatabbott https://t.co/S98ZBm8vNW
RT @AbbottNews We’re well-positioned to deliver another year of top-tier performance and continue to forecast strong #earnings growth for 2021: $ABT #iworkatabbott https://t.co/FVAxUuBpiP
BREAKING: Our BinaxNOW COVID-19 Self Test receives FDA Emergency Use Authorization for asymptomatic, over-the-counter use—no prescription needed.
Learn how frequent testing can help restore a sense of normalcy in everyday settings where people gather: https://t.co/aqPCMYgTHl
Diagnostics saw unprecedented growth as we continued to launch and scale up manufacturing of our COVID-19 tests. And demand isn’t going away – even after vaccines are available. Hear more from our CEO on the future of testing: https://t.co/YL99FOXQL5 $ABT
RT @AbbottNews 1. Trackable progress of pain relief.
2. Data sharing directly with the care team.
3. Support and educational resources.
Here’s how our new NeuroSphere™ myPath™ Digital Health App can help track pain relief
Safety Info: #iworkatabbott https://t.co/94dqjzbrbP
RT @AbbottNews MitraClip is now covered by Medicare for patients with both primary and secondary mitral regurgitation – making it the only minimally invasive mitral valve repair device approved by the FDA & Medicare:
Safety Info: #iworkatabbott https://t.co/PTB3iR6Wfi
RT @AbbottNews We've received CE Mark for our COVID-19 IgG quantitative antibody blood test.
This test can:
1. Provide insight into COVID-19 recovery
2. Help evaluate immune response to a vaccine
Learn more: #iworkatabbott https://t.co/2fGy6hxysO
RT @AbbottNews “By the end of this year, we will have shipped globally over 300 million COVID tests across all of our different platforms.” – Robert Ford, our President and CEO, during @Forbes Healthcare Virtual Summit #ForbesHealth #iworkatabbott https://t.co/cDp65OEe2n
RT @AbbottNews ICYMI: Now there’s another innovative option for the 50 million Americans currently living with chronic pain. The IonicRF™ Generator received FDA clearance for the management of pain in the nervous system. #iworkatabbott https://t.co/LVcLQAxi3E
RT @AbbottNews Heart tech that helps people live healthier. Our fourth-generation MitraClip G4 device received CE Mark, offering an enhanced approach for mitral valve repair in the EU:
Important Safety Info: #iworkatabbott https://t.co/KpaSmQIsAL
Congratulations to all investigators for these interesting results! Another pillar showing the value of imaging and physiology in assessing significance of coronary lesion in patients.
#IWorkAtAbbott
LATE-BREAKING SCIENCE from virtual #SCAI: #OMEF international collaborative study is out. when combined, simple OCT measures like #MLA and area-stenosis may predict #FFR (and outcome if consrvatively-managed)! Congrats to #roccovergallo, Trani and all OMEF investigators!
Good information. #iworkatabbott
Our Update on ID NOW
ID NOW is the fastest molecular point-of-care rapid test available today and has been delivering reliable results when and where they're needed. (1/9)
RT @AbbottNews In addition to our #COVID19 tests, we're continuing the fight by bringing our FreeStyle Libre 14 day technology to frontline healthcare workers. Now they can remotely monitor patients with diabetes in U.S. hospitals:
info: #iworkatabbott https://t.co/YBsi5FPLP4
@BIVDA @LisaBerry1978 Abbott is a BIVDA member. Our scientists and manufacturing teams are working 24/7 on COVID-19 tests. We released a molecular ‘antigen’ test last week. In development- rapid antibody tests and high-volume automated serology testing. Watch this space! #IWorkAtAbbott
RT @AbbottNews BREAKING: We’re launching a test that can detect COVID-19 in as little as 5 minutes—bringing rapid testing to the frontlines. #iworkatabbott #proudtobeabbott https://t.co/iDyQJtWzUt
BREAKING: We’re launching a test that can detect COVID-19 in as little as 5 minutes—bringing rapid testing to the frontlines. https://t.co/LqnRpPpqMM
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.4M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.1M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.7M followers
Taylor Swift
@taylorswift13
82.6M followers
Lady Gaga
@ladygaga
74.1M followers
Virat Kohli
@imvkohli
71.5M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.5M followers
Neymar Jr
@neymarjr
64.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.8M followers
X
@x
60.8M followers